Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

AvePoint Sees Q4 Sales $110.000M-$112.000M vs $107.998M Est

Author: Benzinga Newsdesk | November 06, 2025 04:11pm
AvePoint (NASDAQ:AVPT) sees Q4 sales of $110.000 million-$112.000 million vs $107.998 million analyst estimate.

Posted In: AVPT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist